Enovis Corporation (ENOV) stock declined over -4.47%, trading at $21.79 on NYSE, down from the previous close of $22.81. The stock opened at $22.78, fluctuating between $21.72 and $23.11 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 05, 2026 | 22.78 | 23.11 | 21.72 | 21.79 | 747.28K |
| Feb 04, 2026 | 21.95 | 23.37 | 21.79 | 22.81 | 1.54M |
| Feb 03, 2026 | 22.03 | 22.47 | 21.15 | 21.79 | 1.13M |
| Feb 02, 2026 | 21.97 | 22.78 | 21.72 | 22.17 | 1.4M |
| Jan 30, 2026 | 22.68 | 22.68 | 21.28 | 22.04 | 714.71K |
| Jan 29, 2026 | 21.45 | 22.74 | 21.00 | 22.71 | 1.62M |
| Jan 28, 2026 | 22.01 | 22.10 | 21.19 | 21.46 | 1.34M |
| Jan 27, 2026 | 22.44 | 22.56 | 21.90 | 21.98 | 627.78K |
| Jan 26, 2026 | 23.00 | 23.27 | 22.53 | 22.72 | 899.65K |
| Jan 23, 2026 | 23.32 | 23.43 | 22.50 | 23.01 | 840.49K |
| Jan 22, 2026 | 24.08 | 24.46 | 23.47 | 23.55 | 1.38M |
| Jan 21, 2026 | 23.26 | 23.90 | 23.11 | 23.68 | 980.2K |
| Jan 20, 2026 | 23.20 | 23.81 | 22.98 | 23.09 | 597.93K |
| Jan 16, 2026 | 23.93 | 24.81 | 23.88 | 23.97 | 736.72K |
| Jan 15, 2026 | 24.32 | 24.94 | 24.01 | 24.26 | 920.47K |
| Jan 14, 2026 | 24.49 | 24.79 | 23.58 | 24.27 | 1.36M |
| Jan 13, 2026 | 27.00 | 27.04 | 24.57 | 24.66 | 1.31M |
| Jan 12, 2026 | 29.74 | 29.89 | 26.88 | 26.95 | 1.72M |
| Jan 09, 2026 | 29.10 | 29.78 | 28.09 | 29.68 | 1.1M |
| Jan 08, 2026 | 27.38 | 29.16 | 27.38 | 28.83 | 878.76K |
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
| Employees | 7367 |
| Beta | 1.65 |
| Sales or Revenue | $1.71B |
| 5Y Sales Change% | -0.658% |
| Fiscal Year Ends | December |
| Sector | Industrials |
| Industry | Industrial - Machinery |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep